Richard Vincent | Chief Financial Officer |
Jim Breitmeyer | President & Chief Executive Officer |
Frank Hsu | Chief Medical Officer |
Robert Burns | H.C. Wainwright |
Greetings, and welcome to Oncternal's Q2 Financial Results Call. [Operator Instructions] Please note that this conference call is being recorded. I will now turn the conference over to our host, Richard Vincent, CFO of Oncternal Therapeutics. Thank you.
You may begin.